Empagliflozin, Irrespective of Blood Pressure, Improves Outcomes in Heart Failure with Preserved Ejection Fraction: the Emperor-Preserved Trial
AuthID
P-010-TC0
P-010-TC0
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service